Durata Therapeutics Announces US Launch of Dalvance
July 18, 2014 at 08:05 AM EDT
Durata Therapeutics, Inc. (Nasdaq: DRTX) announced today that DALVANCE (dalbavancin) for injection is now available for use to treat ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.